A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies von Graux, Carlos, Sonet, Anne, Maertens, Johan, Duyster, Justus, Greiner, Jochen, Chalandon, Yves, Martinelli, Giovanni, Hess, Dagmar, Heim, Dominik, Giles, Francis J, Kelly, Kevin R, Gianella-Borradori, Athos, Longerey, Blandine, Asatiani, Ekaterine, Rejeb, Narmyn, Ottmann, Oliver G

Volltext

Abstract C195: Phase I study of 2 dosing regimens of AS703569, an oral Aurora kinase inhibitor, in patients with solid tumors von Mita, Monica, Gordon, Michael, Gianella-Borradori, Athos, Longerey, Blandine, Rejeb, Narmyn, Mendelson, David

Volltext

A phase i dose-escalation study of msc1992371a, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies von Graux, Carlos, Sonet, Anne, Maertens, Johan, Duyster, Justus, Greiner, Jochen, Chalandon, Yves, Martinelli, Giovanni, Hess, Dagmar, Heim, Dominik, Giles, Francis J, Kelly, Kevin R, Gianella-Borradori, Athos, Longerey, Blandine, Asatiani, Ekaterine, Rejeb, Narmyn, Ottmann, Oliver G

Volltext

Abstract 4433: A Phase I study of two dosing regimens of oral AS703569, an inhibitor of aurora kinase and other kinases, in patients with hematologic malignancies von Graux, Carlos, Sonet, Anne, Maertens, Johan, Duyster, Justus, Greiner, Jochen, Chalandon, Yves, Martinelli, Giovanni, Hess, Dagmar, Heim, Dominik, Giles, Frank J., Gianella-Borradori, Athos, Longerey, Blandine, Rejeb, Narmyn, Ottmann, Oliver G.

Volltext

Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies von Sonet, Anne, Graux, Carlos, Maertens, Johan, Hartog, Christine-Maria, Duyster, Justus, Götze, Katharina, Greiner, Jochen, Hütter, Marie-Luise, Gratwohl, Alois, Heim, Dominik, Hess, Dagmar, Chalandon, Yves, Gianella-Borradori, Athos, Rejeb, Narmyn, Ottmann, Oliver

Volltext